miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway

Cellular Oncology

Volumn 39, Issue 1, 2016, Pages 23-33

  Riquelme, Ismael ^a   Tapia, Oscar ^a   Leal, Pamela ^a   Sandoval, Alejandra ^a   Varga, Matthew G ^b   Letelier, Pablo ^c   Buchegger, Kurt ^a   Bizama, Carolina ^d   Espinoza, Jaime A ^d   Peek, Richard M ^b   Araya, Juan Carlos ^a   Roa, Juan Carlos ^d  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSIDAD CATÓLICA DE TEMUCO   (Chile)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Gastric cancer; microRNAs; miR 101 2; miR 125b 2; miR 451a; PI3K AKT mTOR pathway

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MICRORNA 101; MICRORNA 101 2; MICRORNA 125B; MICRORNA 125B 2; MICRORNA 451A; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; TSC1 PROTEIN; UNCLASSIFIED DRUG; MIRN101 MICRORNA, HUMAN; MIRN125 MICRORNA, HUMAN; MIRN451 MICRORNA, HUMAN; PIK3CB PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE; TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER INHIBITION; CELL BEHAVIOR ASSAY; CELL DEATH; CELL DEATH ASSAY; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CELL VIABILITY; CELL VIABILITY ASSAY; CLINICAL ARTICLE; CLONOGENESIS; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; WESTERN BLOTTING; BIOLOGICAL MODEL; CELL MOTION; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; TUMOR INVASION; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CELL DEATH; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TOR SERINE-THREONINE KINASES; TRANSFECTION; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEINS;

EID: 84955353129     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-015-0247-3     Document Type: Article

References (53)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman, Global cancer statistics. CA Cancer J. Clin. 61, 69–90 (2011)
2. A. Yousuf, M.Y. Bhat, A.A. Pandith, D. Afroze, N.P. Khan, K. Alam, P. Shah, M.A. Shah, S. Mudassar, A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman, M.G.M.T. Gene, Silencing by promoter hypermethylation in gastric cancer in a high incidence area. Cell. Oncol. 37, 245–52 (2014)
3. V. Catalano, R. Labianca, G.D. Beretta, G. Gatta, F. de Braud, E. Van Cutsem, Gastric cancer. Crit. Rev. Oncol. Hematol. 71, 127–64 (2009)
4. H.H. Hartgrink, E.P.M. Jansen, N.C.T. van Grieken, C.J.H. van de Velde, Gastric cancer. Lancet 374, 477–490 (2009)
5. M. Labots, T.E. Buffart, J.C. Haan, N.C.T. van Grieken, M. Tijssen, C.J.H. van de Velde, H.I. Grabsch, B. Ylstra, B. Carvalho, R.J.A. Fijneman, H.M.W. Verheul, G.A. Meijer, High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection. Cell. Oncol. 37, 41–52 (2014)
6. B.J. Dicken, D.L. Bigam, C. Cass, J.R. Mackey, A.A. Joy, S.M. Hamilton, Gastric adenocarcinoma: review and considerations for future directions. Ann. Surg. 241, 27–39 (2005)
7. S.-E. Al-Batran, M. Ducreux, A. Ohtsu, mTOR as a therapeutic target in patients with gastric cancer. Int. J. Cancer 130, 491–6 (2012)
8. O. Tapia, I. Riquelme, P. Leal, A. Sandoval, S. Aedo, H. Weber, P. Letelier, E. Bellolio, M. Villaseca, P. Garcia, J.C. Roa, The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance. Virchows Arch. 465, 25–33 (2014)
9. The Cancer Genome Atlas Research Network, Comprehensive Molecular Characterization of Gastric Adenocarcinoma. Nature. 513, 202–9 (2014)
10. E. Caron, S. Ghosh, Y. Matsuoka, D. Ashton-Beaucage, M. Therrien, S. Lemieux, C. Perreault, P.P. Roux, H. Kitano, A comprehensive map of the mTOR signaling network. Mol. Syst. Biol. 6, 453 (2010)
11. D. Morgensztern, H.L. McLeod, PI3K/Akt/mTOR pathway as a target for cancer therapy. Anticancer Drugs 16, 797–803 (2005)
12. D.P. Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–97 (2004)
13. Y. Wang, M. Li, W. Zang, Y. Ma, N. Wang, P. Li, T. Wang, G. Zhao, MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma. Cell. Oncol. 36, 385–94 (2013)
14. T.A. Farazi, J.I. Hoell, P. Morozov, T. Tuschl, MicroRNAs in human cancer. Adv. Exp. Med. Biol. 774, 1–20 (2013)
15. A. Esquela-Kerscher, F.J. Slack, Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259–69 (2006)
16. R. Nagadia, P. Pandit, W.B. Coman, J. Cooper-White, C. Punyadeera, miRNAs in head and neck cancer revisited. Cell. Oncol. 36, 1–7 (2013)
17. C.M. Croce, G.A. Calin, miRNAs, cancer, and stem cell division. Cell 122, 6–7 (2005)
18. K.N. Ivey, D. Srivastava, MicroRNAs as regulators of differentiation and cell fate decisions. Cell Stem Cell 7, 36–41 (2010)
19. R. Garzon, M. Fabbri, A. Cimmino, G.A. Calin, C.M. Croce, MicroRNA expression and function in cancer. Trends Mol. Med. 12, 580–7 (2006)
20. W.C.S. Cho, OncomiRs: the discovery and progress of microRNAs in cancers. Mol. Cancer 6, 60 (2007)
21. M. Fabbri, miRNAs as molecular biomarkers of cancer. Expert Rev. Mol. Diagn. 10, 435–44 (2010)
22. E. Chan, D.E. Prado, J.B. Weidhaas, Cancer microRNAs: from subtype profiling to predictors of response to therapy. Trends Mol. Med. 17, 235–43 (2011)
23. A. Strillacci, C. Griffoni, P. Sansone, P. Paterini, G. Piazzi, G. Lazzarini, E. Spisni, M.A. Pantaleo, G. Biasco, V. Tomasi, MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp. Cell Res. 315, 1439–47 (2009)
24. R.B. Batchu, O. Gruzdyn, A.M. Qazi, D. Bouwman, S.A. Gruber, D.W. Weaver, MicroRNA-101 (miR-101) enhances chemosensitivity of pancreatic ductal adenocarcinoma (PDAC) cells by inhibition of MTOR signaling Via PRAS40. J. Surg. Res. 172, 233 (2012)
25. J. Buechner, E. Tømte, B.H. Haug, J.R. Henriksen, C. Løkke, T. Flægstad, C. Einvik, Tumour-suppressor microRNAs Let-7 and Mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma. Br. J. Cancer 105, 296–303 (2011)
26. C.-W. Chiang, Y. Huang, K.-W. Leong, L.-C. Chen, H.-C. Chen, S.-J. Chen, C.-K. Chou, PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells. J. Biomed. Sci. 17, 35 (2010)
27. L. Liang, C.-M. Wong, Q. Ying, D.N.-Y. Fan, S. Huang, J. Ding, J. Yao, M. Yan, J. Li, M. Yao, I.O.-L. Ng, X. He, MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepatology 52, 1731–40 (2010)
28. L. Liu, H. Li, J. Li, H. Zhong, H. Zhang, J. Chen, T. Xiao, miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3. Biochem. Biophys. Res. Commun. 416, 31–8 (2011)
29. G.K. Scott, A. Goga, D. Bhaumik, C.E. Berger, C.S. Sullivan, C.C. Benz, Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J. Biol. Chem. 282, 1479–86 (2007)
30. E. Bandres, N. Bitarte, F. Arias, J. Agorreta, P. Fortes, X. Agirre, R. Zarate, J.A. Diaz-Gonzalez, N. Ramirez, J.J. Sola, P. Jimenez, J. Rodriguez, J. Garcia-Foncillas, microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin. Cancer Res. 15, 2281–90 (2009)
31. Y. Nan, L. Han, A. Zhang, G. Wang, Z. Jia, Y. Yang, X. Yue, P. Pu, Y. Zhong, C. Kang, MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res. 1359, 14–21 (2010)
32. J. Godlewski, M.O. Nowicki, A. Bronisz, G. Nuovo, J. Palatini, M. De Lay, J. Van Brocklyn, M.C. Ostrowski, E.A. Chiocca, S.E. Lawler, MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol. Cell 37, 620–32 (2010)
33. H. Zhou, J.-M. Guo, Y.-R. Lou, X.-J. Zhang, F.-D. Zhong, Z. Jiang, J. Cheng, B.-X. Xiao, Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J. Mol. Med. (Berl.) 88, 709–17 (2010)
34. H.-J. Wang, H.-J. Ruan, X.-J. He, Y.-Y. Ma, X.-T. Jiang, Y.-J. Xia, Z.-Y. Ye, H.-Q. Tao, MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur. J. Cancer 46, 2295–2303 (2010)
35. Z.-X. Yang, C.-Y. Lu, Y.-L. Yang, K.-F. Dou, K.-S. Tao, MicroRNA-125b expression in gastric adenocarcinoma and its effect on the proliferation of gastric cancer cells. Mol. Med. Rep. 7, 229–232 (2013)
36. Y. Cheng, L. Chen, X. Cao, S. Ha, X. Xia, Expression profiling and functional analysis of hsa-miR-125b and its target genes in drug-resistant cell line of human gastric cancer. Hereditas 36, 119–128 (2014)
37. J.G. Clohessy, M. Reschke, P.P. Pandolfi, Found in translation of mTOR signaling. Cell Res. 22, 1315–8 (2012)
38. I. Beuvink, A. Boulay, S. Fumagalli, F. Zilbermann, S. Ruetz, T. O’Reilly, F. Natt, J. Hall, H.A. Lane, G. Thomas, The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation. Cell 120, 747–59 (2005)
39. H. Zhou, S. Huang, Role of mTOR signaling in tumor cell motility, invasion and metastasis. Curr. Protein Pept. Sci. 12, 30–42 (2011)
40. M.F. Crouch, Regulation of thrombin-induced stress fibre formation in swiss 3T3 cells by the 70-kDa S6 kinase. Biochem. Biophys. Res. Commun. 233, 193–9 (1997)
41. L.A. Berven, F.S. Willard, M.F. Crouch, Role of the p70(S6K) pathway in regulating the actin cytoskeleton and cell migration. Exp. Cell Res. 296, 183–95 (2004)
42. K. Sakakibara, B. Liu, S. Hollenbeck, K.C. Kent, Rapamycin inhibits fibronectin-induced migration of the human arterial smooth muscle line (E47) through the mammalian target of rapamycin. Am. J. Physiol. Heart Circ. Physiol. 288, H2861–H2868 (2005)
43. H.Y. Zhou, A.S.T. Wong, Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells. Endocrinology 147, 2557–66 (2006)
44. S.A. Lang, A. Gaumann, G.E. Koehl, U. Seidel, F. Bataille, D. Klein, L.M. Ellis, U. Bolder, F. Hofstaedter, H.-J. Schlitt, E.K. Geissler, O. Stoeltzing, Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model. Int. J. Cancer 120, 1803–10 (2007)
45. A. Akinleye, P. Avvaru, M. Furqan, Y. Song, D. Liu, Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics. J. Hematol. Oncol. 6, 88 (2013)
46. W. Li, L. Xie, X. He, J. Li, K. Tu, L. Wei, J. Wu, Y. Guo, X. Ma, P. Zhang, Z. Pan, X. Hu, Y. Zhao, H. Xie, G. Jiang, T. Chen, J. Wang, S. Zheng, J. Cheng, D. Wan, S. Yang, Y. Li, J. Gu, Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int. J. Cancer 123, 1616–22 (2008)
47. E.J. Ezratty, C. Bertaux, E.E. Marcantonio, G.G. Gundersen, Clathrin mediates integrin endocytosis for focal adhesion disassembly in migrating cells. J. Cell Biol. 187, 733–47 (2009)
48. J.S. Desgrosellier, D.A. Cheresh, Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 10, 9–22 (2010)
49. H.A. Dbouk, J.M. Backer, A beta version of life: p110β takes center stage. Oncotarget 1, 729–33 (2010)
50. D. Kim, S. Kim, H. Koh, S.O. Yoon, A.S. Chung, K.S. Cho, J. Chung, Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J. 15, 1953–62 (2001)
51. Y.R. Chin, A. Toker, Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. Cell. Signal. 21, 470–6 (2009)
52. B. Brenner, M.B. Hoshen, O. Purim, M. Ben David, K. Ashkenazi, G. Marshak, Y. Kundel, R. Brenner, S. Morgenstern, M. Halpern, N. Rosenfeld, A. Chajut, Y. Niv, M. Kushnir, MicroRNAs as a potential prognostic factor in gastric cancer. World J. Gastroenterol. 17, 3976–85 (2011)
53. M.D. Jansson, A.H. Lund, MicroRNA and cancer. Mol. Oncol. 6, 590–610 (2012)